HealthUS FDA expands Novartis drug’s use for chronic skin condition

Novartis said on Wednesday that the US Food and Drug Administration expanded the use of its drug to treat adults with a chronic skin condition that causes recurring itchy welts.

drug approvalNovartisUS FDA

RReuters★★☆☆☆2026-10-07 18:35Original